396 related articles for article (PubMed ID: 15082651)
1. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses.
van Valkengoed IG; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; Boeke AJ
Int J Epidemiol; 2004 Apr; 33(2):416-25. PubMed ID: 15082651
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening.
Land JA; Van Bergen JE; Morré SA; Postma MJ
Hum Reprod Update; 2010; 16(2):189-204. PubMed ID: 19828674
[TBL] [Abstract][Full Text] [Related]
3. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Coutinho RA; Jager JC
Ned Tijdschr Geneeskd; 1999 Mar; 143(13):677-81. PubMed ID: 10321301
[TBL] [Abstract][Full Text] [Related]
4. [Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
Postma MJ; Bakker A; Welte R; van Bergen JE; van den Hoek JA; de Jong-van den Berg LT; Jager JC
Ned Tijdschr Geneeskd; 2000 Dec; 144(49):2350-4. PubMed ID: 11129971
[TBL] [Abstract][Full Text] [Related]
5. The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women.
Gift TL; Gaydos CA; Kent CK; Marrazzo JM; Rietmeijer CA; Schillinger JA; Dunne EF
Sex Transm Dis; 2008 Nov; 35(11 Suppl):S66-75. PubMed ID: 18830137
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.
Norman JE; Wu O; Twaddle S; Macmillan S; McMillan L; Templeton A; McKenzie H; Noone A; Allardice G; Reid M
BJOG; 2004 Nov; 111(11):1261-8. PubMed ID: 15521872
[TBL] [Abstract][Full Text] [Related]
7. Risk of sequelae after Chlamydia trachomatis genital infection in women.
Haggerty CL; Gottlieb SL; Taylor BD; Low N; Xu F; Ness RB
J Infect Dis; 2010 Jun; 201 Suppl 2():S134-55. PubMed ID: 20470050
[TBL] [Abstract][Full Text] [Related]
8. The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland.
Gillespie P; O'Neill C; Adams E; Turner K; O'Donovan D; Brugha R; Vaughan D; O'Connell E; Cormican M; Balfe M; Coleman C; Fitzgerald M; Fleming C
Sex Transm Infect; 2012 Apr; 88(3):222-8. PubMed ID: 22213681
[TBL] [Abstract][Full Text] [Related]
9. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
Ruitenberg EN
Ned Tijdschr Geneeskd; 1999 May; 143(19):1012. PubMed ID: 10368724
[No Abstract] [Full Text] [Related]
10. Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens.
van Valkengoed IG; Postma MJ; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; Boeke AJ
Sex Transm Infect; 2001 Aug; 77(4):276-82. PubMed ID: 11463928
[TBL] [Abstract][Full Text] [Related]
11. Universal screening or prophylactic treatment for Chlamydia trachomatis infection among women seeking induced abortions: which strategy is more cost-effective?
Chen S; Li J; van den Hoek A
Sex Transm Dis; 2007 Apr; 34(4):230-6. PubMed ID: 17414068
[TBL] [Abstract][Full Text] [Related]
12. Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know?
Gottlieb SL; Berman SM; Low N
J Infect Dis; 2010 Jun; 201 Suppl 2():S156-67. PubMed ID: 20470051
[TBL] [Abstract][Full Text] [Related]
13. The incidence of pelvic inflammatory disease in untreated women infected with Chlamydia trachomatis: a structured review.
Risser WL; Risser JM
Int J STD AIDS; 2007 Nov; 18(11):727-31. PubMed ID: 18005504
[TBL] [Abstract][Full Text] [Related]
14. Should asymptomatic patients be tested for Chlamydia trachomatis in general practice?
Buhaug H; Skjeldestad FE; Halvorsen LE; Dalen A
Br J Gen Pract; 1990 Apr; 40(333):142-5. PubMed ID: 2115349
[TBL] [Abstract][Full Text] [Related]
15. [Chlamydia trachomatis infection in men and its association with gynecologic alterations in their sexual partners].
Guerra-Infante FM; Tapia-Yáñez JR; López-Hurtado M; Flores-Medina S; Díaz-García FJ
Rev Invest Clin; 2005; 57(3):406-14. PubMed ID: 16187700
[TBL] [Abstract][Full Text] [Related]
16. The impact of natural history parameters on the cost-effectiveness of Chlamydia trachomatis screening strategies.
Hu D; Hook EW; Goldie SJ
Sex Transm Dis; 2006 Jul; 33(7):428-36. PubMed ID: 16572038
[TBL] [Abstract][Full Text] [Related]
17. [Chlamydia trachomatis: should it be systematically be screened or treated? Literature review and cost/benefit estimation in France].
Henry-Suchet J; Sluzhinska A; Serfaty D
Contracept Fertil Sex; 1998 Feb; 26(2):151-8. PubMed ID: 9560916
[TBL] [Abstract][Full Text] [Related]
18. Productivity losses attributable to untreated chlamydial infection and associated pelvic inflammatory disease in reproductive-aged women.
Blandford JM; Gift TL
Sex Transm Dis; 2006 Oct; 33(10 Suppl):S117-21. PubMed ID: 17003678
[TBL] [Abstract][Full Text] [Related]
19. A cost-based decision analysis for Chlamydia screening in California family planning clinics.
Trachtenberg AI; Washington AE; Halldorson S
Obstet Gynecol; 1988 Jan; 71(1):101-8. PubMed ID: 3122137
[TBL] [Abstract][Full Text] [Related]
20. Trends of reported chlamydia infections and related complications in New Zealand, 1998-2008.
Morgan J; Colonne C; Bell A
Sex Health; 2011 Sep; 8(3):412-8. PubMed ID: 21851784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
